AbbVie (ABBV) Revenue — Quarter Ended Sep 30, 2025
Revenue for the quarter increased compared to the prior quarter and rose relative to the same quarter last year. The sequential gain was modest, while the year-over-year growth was more pronounced.
Key takeaway
Quarter ended Sep 30, 2025 · FY2025 Q3
Revenue for the quarter increased compared to the prior quarter and rose relative to the same quarter last year. The sequential gain was modest, while the year-over-year growth was more pronounced.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$15.8B
Revenue reported for this quarter.
Quarter-over-quarter
+2.3%
Change from the immediately preceding quarter.
Year-over-year
+9.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$59.6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2024 | $15.1B | +5.6% |
| Mar 31, 2025 | $13.3B | +8.4% |
| Jun 30, 2025 | $15.4B | +6.6% |
| Sep 30, 2025 | $15.8B | +9.1% |
Revenue performance
The reported revenue moved higher, continuing the upward trajectory seen in recent quarters. The increase from the preceding quarter was smaller than the gain from the same quarter a year earlier.
Quarterly comparison
Compared with the immediately preceding quarter, revenue improved. Versus the same quarter one year earlier, revenue also increased, with the year-over-year change exceeding the sequential change.
What to watch
The filing context does not provide specific forward-looking guidance; monitor future filings for any updates on revenue drivers.